With that in mind, we focus on developing lasting, well-aligned partnerships with exceptional entrepreneurs and executives to build valuable companies. In addition to capital, we provide deep healthcare domain expertise and an extensive network of industry contacts and resources.

Learn More
January 24, 2018 Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.
Read More
January 22, 2018 Lyric Pharma Granted FDA Fast Track Designation for Lead Product Ulimorelin for Enteral Feeding Intolerance (EFI)
Read More